These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9210357)

  • 21. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
    Döme B; Somlai B; Tímár J
    Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of surgery in the treatment of malignant melanoma].
    Péley G; Farkas E; Mátrai Z; Rényi-Vámos F; Kovács T; Köves I
    Magy Onkol; 2003; 47(1):69-77. PubMed ID: 12704458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
    Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth control by tumor suppressors in malignant melanoma.
    Coleman A; Robertson G; Lugo TG
    Receptor; 1995; 5(1):9-19. PubMed ID: 7613487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
    Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
    Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
    Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
    Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death.
    Chen LL; Nolan ME; Silverstein MJ; Mihm MC; Sober AJ; Tanabe KK; Smith BL; Younger J; Michaelson JS
    Cancer; 2009 Nov; 115(21):5071-83. PubMed ID: 19658184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node status in melanoma: a valuable prognostic factor?
    Topar G; Eisendle K; Zelger B; Fritsch P
    Br J Dermatol; 2006 Jun; 154(6):1080-7. PubMed ID: 16704637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma.
    Galliot-Repkat C; Cailliod R; Trost O; Danino A; Collet E; Lambert D; Vabres P; Dalac S
    Eur J Surg Oncol; 2006 Sep; 32(7):790-4. PubMed ID: 16822643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-stage melanoma: staging criteria and prognostic modeling.
    Ross MI
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2312s-2319s. PubMed ID: 16609051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
    McHugh JB; Su L; Griffith KA; Schwartz JL; Wong SL; Cimmino V; Chang AE; Johnson TM; Sabel MS
    Ann Surg Oncol; 2006 Sep; 13(9):1216-23. PubMed ID: 16952026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The importance of prognostic factors in malignant melanoma of the skin].
    Bischoff I; Wozniak KD
    Arch Geschwulstforsch; 1989; 59(6):463-7. PubMed ID: 2596960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.